LungLife AI Inc
LLAI
Company Profile
Business description
LungLife AI Inc is focused on a developing clinical diagnostic solutions for lung cancer. The Company generates revenue from People’s Republic of China and also has its presence in the United States of America.
Contact
2545 W. Hillcrest Drive
Suite 140
Thousand OaksCA91320
USAT: +1 805 409-9868
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
13
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,847.60 | 205.10 | -2.55% |
| CAC 40 | 7,314.32 | 284.66 | -3.75% |
| DAX 40 | 20,855.28 | 862.11 | -3.97% |
| Dow JONES (US) | 39,611.52 | 934.41 | -2.30% |
| FTSE 100 | 8,139.59 | 335.15 | -3.95% |
| HKSE | 22,849.81 | 352.72 | -1.52% |
| NASDAQ | 16,096.11 | 454.49 | -2.75% |
| Nikkei 225 | 33,780.58 | 955.35 | -2.75% |
| NZX 50 Index | 12,225.28 | 113.29 | -0.92% |
| S&P 500 | 5,253.10 | 143.42 | -2.66% |
| S&P/ASX 200 | 7,667.80 | 191.90 | -2.44% |
| SSE Composite Index | 3,342.01 | 8.12 | -0.24% |